Month: August 2021

GLEN BURNIE, Md., Aug. 05, 2021 (GLOBE NEWSWIRE) — Glen Burnie Bancorp (“Bancorp”) (NASDAQ: GLBZ), the bank holding company for The Bank of Glen Burnie (“Bank”), announced today net income of $480,000, or $0.17 per basic and diluted common share for the three-month period ended June 30, 2021, as compared to a net loss of $96,000, or $0.03 per basic and diluted common share for the three-month period ended June 30, 2020. Bancorp reported net income of $1,074,000, or $0.38 per basic and diluted common share for the six-month period ended June 30, 2021, compared to $174,000, or $0.06 per basic and diluted common share for the same period in 2020. On June 30, 2021, Bancorp had total assets of $432.8 million. Bancorp, the oldest independent commercial bank in Anne Arundel County, paid its 116th consecutive quarterly dividend on July...

$RNWR – 808 Renewable Energy CorporationMSRP of the Orca Roadster starts at only $9,900$RNWR – 808 Renewable Energy CorporationSilverLight Electric Vehicle$RNWR – 808 Renewable Energy CorporationFederal Tax Credit$RNWR – 808 Renewable Energy CorporationFORM 8834 – Qualified Electric Vehicle CreditBradenton, Florida, Aug. 05, 2021 (GLOBE NEWSWIRE) — 808 Renewable Energy Corporation (OTC Pink: RNWR) (“808” or the “Company”), today announces that the Company is about to launch its local advertising campaign to promote and introduce its first electric reverse-trike model – the Orca Roadster. “We have successfully passed the Trademark Application Filing Stage and now entering into the Examination Process with the U.S. Patent &...

New York, NY, and Tel Aviv, ISRAEL, Aug. 05, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced it has received a notice of allowance from the US Patent & Trademark Office (USPTO) for a trademark for the Company’s proprietary supplement Tollovid™. The Company received a Certificate of Free Sale (CFS) for the 5-day high dose regimen of Tollovid from the US Food & Drug Administration (US FDA) in April 2021. This USPTO notice of allowance underscores the desire in the marketplace for Tollovid, especially given its high dose, 5-day formulation that helps to support and maintain healthy immune function. Tollovid is a potent botanical, delayed release, bioavailable 3CL protease inhibitor. The Company’s lower...

Coconut Creek, FL, Aug. 05, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — NutraLife Biosciences, Inc. (“NutraLife” or the “Company”) (OTC: NLBS) is pleased to announce that it has obtained current, fully reporting status through the filing of the Company’s financial statements. Please see the following link below to the Company’s financial statements filed with the Securities and Exchange Commission. NutraLife is excited about the potential this step creates for future growth of the Company. The Company’s continued focus is on increasing its revenue, a goal it intends to achieve through the distribution and sale of the Company’s lifestyle health and wellness, nutraceutical, and skincare branded product lines. As a lifestyle health and wellness manufacturing firm, NutraLife is dedicated to creating growth through the high-quality,...

SAINT LAURENT, Quebec, Aug. 05, 2021 (GLOBE NEWSWIRE) — IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) announces the closing of an offering by way of private placement (the “Offering”) to certain investors in the United States of 8% convertible notes due July 31, 2025 (the “Notes”) for aggregate gross proceeds of approximately U.S.$2.1 million. The Notes will bear interest at a rate of 8% per annum, payable quarterly, and will be convertible into shares of common stock of the Company (the “Shares”) beginning 6 months after their issuance at a price of U.S.$0.40 per Share. Cantone Research, Inc. (“Cantone”) acted as placement agent in respect of the Offering. The Company intends to use the proceeds of the Offering to finance its Montelukast study. In connection with the Offering, the Company...

$GDET – GD Entertainment and TechnologyDual Crypto DreamcardFort Lee, New Jersey, Aug. 05, 2021 (GLOBE NEWSWIRE) — GD Entertainment and Technology (OTC Pink: GDET) (“GDET” or the “Company”) (https://gdetco.com), a Company focused on high growth industries related to the Crypto Space, is pleased to announce that it has officially launched its Dreamcard, the world’s first Crypto/Fiat Dual Debit/Credit Card, containing a dual-chip and issued as a notably sleek polished metal card, and it traditional single debit/fiat/reloadable model. The Company has targeted four key strategies: Celebrities/ Influencers Membership Groups Charities Retail single usersCelebrity/Influencer based marketing will focus on leveraging significant fan/follower base in an impactful manner in a model that involves a revenue share...